Navigation Links
ITMN in Medical News

Important Data Presented on Independent Predictors of Mortality in Patients With Idiopathic Pulmonary Fibrosis

...orced Vital Capacity is among strongest predictors of one-year mortality - SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today reported that results of a study assessing the relationship between various measures of clinical status and the risk of death in patients with...

InterMune to Present at Cowen Health Care Conference

... BRISBANE, Calif., March 13 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that Daniel G. Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Cowen and Company 29th Annua...

InterMune Reports Results from Triple Combination Study of ITMN-191

...gin in Q2 2009 - - Conference call today at 8:30 a.m. EST - BRISBANE, Calif., Jan. 12 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today reported top-line results from all six completed dosage cohorts of its Phase 1b clinical trial of ITMN-191 (R7227) in combination with standar...

InterMune to Present at Thomas Weisel Partners Healthcare Conference

... BRISBANE, Calif., Aug. 29 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the Thomas Weisel Partners Healthcare Conference in ...

InterMune to Present at the 2008 Wachovia Healthcare Conference

... BRISBANE, Calif., Jan. 23 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that Steven Porter, M.D., Ph.D., Chief Medical Officer of InterMune, will present at the 2008 Wachovia Healthcare Conference in Bost...

HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...ics Inc RESP 157248157.2 Theravance Inc THRX 212837798.5 Intermune Inc itmn 296874543.2 Sepracor Inc. SEPR 385036542.3 Nektar Therapeutics NKTR 1272671080 Encys...
ITMN in Medical Technology

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

...eported - - Conference Call and Webcast at 9 p.m. EDT (6 p.m. PDT) - SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) reported that results from the two Phase 3 CAPACITY studies evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were present...

Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen

...nts with hepatitis C - NUTLEY, N.J., BRISBANE, Calif., and PRINCETON, N.J., April 25 /PRNewswire-FirstCall/ -- Roche, InterMune, Inc. (Nasdaq: itmn ) and Pharmasset (Nasdaq: VRUS ) today announced the first results from their innovative, interferon-free regimen of direct acting antiviral (DAA) c...

InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)

...dy - -- Phase 2b program anticipated to begin in summer 2009 -- COPENHAGEN , April 24 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that results from a 14-day Phase 1b clinical study of ITMN-191 (R7227) in combination with the current standard of care were present...

InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3

... BRISBANE, Calif., Feb. 2 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that it will report results from its Phase 3 CAPACITY program of pirfenidone in idiopathic pulmonary fibrosis (IPF) prior to market ...

InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191

... BRISBANE, Calif., Jan. 9 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that it will conduct a conference call and webcast on Monday, January 12 at 8:30 a.m. EST to discuss results from its Phase 1b, 14-d...

InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009

... BRISBANE, Calif., Dec. 10 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today said that it will report top-line results in January 2009 from its Phase 1b clinical trial of protease inhibitor ITMN-191 (R7227) in combinati...

Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C

... PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ), Roche (SWX: ROG) and InterMune, Inc. (Nasdaq: itmn ) today announced that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus ...

InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C

...nued development in treatment-experienced patients - BRISBANE, Calif., May 29 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that it has begun dosing in its Phase 1b clinical trial evaluating ITMN-191, designated R7227 at Roche (SWX: ROG), in combination wi...

InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA

...s Shionogi Phase 3 results on pirfenidone - BRISBANE, Calif., May 19 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that its program for the development of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) has received "Fast Trac...

InterMune Announces Progress on Pirfenidone in IPF

...ne study now available on ATS website - BRISBANE, Calif., April 21 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that it will initiate an open-label roll-over study to evaluate the long-term safety of pirfenidone in patients with idiopathic pulm...
ITMN in Biological Technology

InterMune to Present at Canaccord Adams Conference

... BRISBANE, Calif., Aug. 7 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Canaccord Adams 29th Annual Global...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

... BRISBANE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced results from operations for the second quarter and six months ended June 30, 2009. InterMune reported a net loss for the second q...

InterMune to Release Second Quarter Financial Results on August 6

... BRISBANE, Calif., July 29 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) announced today that it will release second quarter 2009 financial results on Thursday, August 6, 2009 at 4:00 p.m. Eastern time. A live conference...

InterMune to Present at Goldman Sachs Healthcare Conference

... BRISBANE, Calif., June 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that Daniel Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Goldman Sachs 30th Annual Globa...

Results From Phase 3 CAPACITY Program of Pirfenidone in IPF and Study of Predictors of Mortality in IPF to be Presented at ATS

... - Conference call and webcast Tuesday, May 19, 6 p.m. PDT - BRISBANE, Calif., May 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that an oral late-breaker presentation and two poster discussion presentations related to the company's pulmonology programs will be...

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

... data from 14-day triple combination study of ITMN-191 in HCV - BRISBANE, Calif. , April 30 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced results from operations for the first quarter ended March 31, 2009. InterMune reported a net loss for the first quarter of 2009 o...

INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients

... - Twice-Daily Dosing and Higher Doses of ITMN-191 (R7227) - BRISBANE, Calif., April 21 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that the innovative clinical study of protease inhibitor ITMN-191 (R7227) in combination with nucleoside polymerase inhibitor R7128 ...

InterMune to Release First Quarter Financial Results on April 30

... BRISBANE, Calif., April 21 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) announced today that it will release first quarter 2009 financial results on Thursday, April 30, 2009 at 4:00 p.m. Eastern time. A live conference ...

InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25

... -- Conference Call and Webcast Scheduled -- BRISBANE, Calif., April 20 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that InterMune and Pharmasset, Inc. will host a live webcast of a discussion of the INFORM-1 results from the EASL conference on Sat...

InterMune to Present at Canaccord Adams Hepatitis C Conference

... BRISBANE, Calif., April 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: itmn ) today announced that Steven B. Porter, M.D., Ph.D., Chief Medical Officer of InterMune, will present at the Canaccord Adams Hepatitis C Conference o...
Other Tags
(Date:5/20/2013)... 2013 The nationwide law firm of Bernstein ... magnetic resonance imaging (MRI) can be used to predict ... patients are experiencing symptoms. According to an article published ... Joint Surgery, MRI detected synovitis (tissue damage) in 68% of ... to mechanical causes, the detection rate was 75%, while MRIs ...
(Date:5/20/2013)... whose mother lived near heavy traffic while pregnant faces ... before the age of 3, a new study suggests. ... of mothers and infants from eastern Massachusetts. All the ... of pregnancy at some point between 1999 and 2002. ... 100 meters (about 110 yards) from a major roadway, ...
(Date:5/20/2013)... is it about toothpaste that transforms the sweet flavor ... solution to that mysterious sensory phenomenon in colorful, ... American Chemical Society,s award-winning Bytesize Science video ... the world,s largest scientific society, explains that the mainstay ... sulfate, or SLS for short. When you brush your ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Join Seva Foundation ... concert at the Palace of Fine Arts Theater ... Uttal , C.C. White and Shimshai, with host Wavy Gravy. ... the world. , Reserved seats are $40 & ... with the artists and a front row seat at the ...
(Date:5/20/2013)... 20, 2013 Cliff Lake Dental Care is pleased ... patient schedules when visiting the dentist office . The change ... life schedule. , Here are the new office hours: Mondays- 8 ... – 8 a.m. to 1 p.m. and 2-5 p.m., Thursdays 7 ... office will be open to take appointments only. Cliff Lake Dental ...
Breaking Medicine News(10 mins):Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:Cliff Lake Dental Care Announces Office Hours Change 2
(Date:5/16/2013)... developed at MIT may someday eliminate the need ... monitor their blood-sugar levels and inject themselves with ... glucose levels in the body and respond by ... the function of pancreatic islet cells, which are ... this type of system could ensure that blood-sugar ...
(Date:5/16/2013)... players and athletes choose to wear the color red ... in Psychological Science , a journal of the ... to do with their testosterone levels. , The new ... University of Sunderland and colleagues, demonstrated that males who ... had higher testosterone levels than other males who chose ...
(Date:5/16/2013)... years old give unprecedented insight into the evolutionary ... most species-rich groups among the modern bony fishes. ... from the Division of Paleontology and Geobiology at ... Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have completed ... assign to the group of bony fishes that ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
Other Contents